Synergy CHC (NASDAQ:SNYR) Upgraded to Buy at Wall Street Zen

Synergy CHC (NASDAQ:SNYR) was upgraded by analysts at Wall Street Zen to a “buy” rating in a research report issued to clients and investors on Saturday.

Synergy CHC Stock Performance

Shares of NASDAQ SNYR opened at $2.65 on Friday. Synergy CHC has a 1 year low of $0.36 and a 1 year high of $10.00. The firm’s 50 day moving average price is $2.06 and its 200 day moving average price is $2.26.

Synergy CHC (NASDAQ:SNYR) last announced its earnings results on Thursday, May 15th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.07 by $0.03. The firm had revenue of $8.17 million for the quarter, compared to analyst estimates of $9.03 million. On average, equities research analysts forecast that Synergy CHC will post 0.36 earnings per share for the current fiscal year.

Institutional Trading of Synergy CHC

A number of hedge funds have recently bought and sold shares of the company. Global Retirement Partners LLC acquired a new stake in Synergy CHC during the fourth quarter worth approximately $36,000. Sanders Morris Harris LLC raised its stake in Synergy CHC by 3.4% during the first quarter. Sanders Morris Harris LLC now owns 391,485 shares of the company’s stock worth $920,000 after purchasing an additional 12,930 shares during the period. Paloma Partners Management Co purchased a new position in Synergy CHC during the fourth quarter worth approximately $97,000. Finally, Gratia Capital LLC purchased a new position in Synergy CHC during the fourth quarter worth approximately $466,000.

About Synergy CHC

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.